Birss J excuses Chugai from tocilizumab royalties in UCB "validity tie breaker" By Annsley Merelle Ward at Friday, August 24, 2018 AmeriKat Birss J Celltech chugai claim construction declaratory relief patent licence patent licences royalties ucb US claim construction US law +